Behavioral Cough Suppression Therapy for Chronic Cough
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new methods to assist individuals with chronic cough unresponsive to standard treatments. It tests three approaches: Behavioral Cough Suppression Therapy, a hot pepper extract called capsaicin that may reduce cough sensitivity, and a combination of both. Participants will attend 12 sessions to evaluate the treatments' effects on cough sensitivity, cough control, brain response to cough triggers, and overall quality of life. The trial seeks adults with a long-term cough not explained by other health issues and unchanged despite normal lung tests in the past two years. As a Phase 2 trial, this research focuses on assessing the treatment's effectiveness in an initial, smaller group.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have used an ACE-inhibitor in the past 60 days, you cannot participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both behavioral cough suppression therapy (BCST) and capsaicin inhalation are generally safe for people with chronic cough. Studies have found that BCST can improve cough symptoms in up to 87% of patients. This therapy typically requires no more than four sessions and is considered effective and affordable.
For capsaicin inhalation, research suggests it is safe and well tolerated. Capsaicin, the ingredient that makes chili peppers spicy, has been used in various forms to reduce cough sensitivity. One study found that inhaling capsaicin is safe and tolerable, even for people with sensitive airways.
While both treatments are generally well tolerated, individual experiences may vary. Consulting a healthcare provider before joining a clinical trial is always advisable.12345Why are researchers excited about this trial's treatments?
Researchers are excited about Behavioral Cough Suppression Therapy (BCST) because it offers a non-drug approach to managing chronic cough, differing from typical treatments like cough syrups and medications that primarily aim to suppress symptoms. This method focuses on training individuals to consciously control their cough reflex through specific behavioral techniques. Additionally, when combined with an inhaled vaporized drug, it potentially enhances the therapy's effectiveness by working to desensitize the cough reflex itself. This approach not only targets symptom relief but also addresses the underlying mechanism, potentially providing a more sustainable solution for chronic cough sufferers.
What evidence suggests that this trial's treatments could be effective for chronic cough?
Studies have shown that behavioral cough suppression therapy (BCS) is effective for individuals with chronic cough. Many patients experience a significant reduction in cough frequency, with some studies indicating success up to 88% of the time. Research indicates that BCS helps patients better control their urge to cough and enhances their quality of life.
In this trial, participants will receive different treatments. One group will receive behavioral cough suppression therapy combined with an inactive inhaled substance. Another group will receive behavioral cough suppression therapy combined with an inhaled vaporized drug designed to enhance BCS. Capsaicin, the active ingredient in chili peppers, has been studied for its effects on chronic cough and is known to reduce the sensitivity of the cough reflex, leading to fewer and milder coughing episodes. In this trial, one group will inhale a drug designed to desensitize the cough reflex, potentially including capsaicin. Combining BCS with such a drug may yield the best results by both improving cough control and reducing sensitivity to cough triggers.12678Who Is on the Research Team?
Laurie J Slovarp, PhD
Principal Investigator
University of Montana
Marie Jetté, PhD
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
This trial is for adults with chronic cough that hasn't improved with standard treatments. Participants will be taught techniques to suppress coughing and may inhale capsaicin or a placebo. They must attend 12 sessions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive one of three treatments: BCS therapy with capsaicin, BCS therapy with placebo, or capsaicin stimulation alone, over 12 sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment, including cough sensitivity and suppression ability
What Are the Treatments Tested in This Trial?
Interventions
- Behavioral Cough Suppression Therapy
- Capsaicin
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Montana
Lead Sponsor
Emory University
Collaborator
University of Colorado, Denver
Collaborator
University of Melbourne
Collaborator